Total Payments
$15,820
2024 Payments
$2,078
Companies
59
Transactions
828
Medicare Patients
1,970
Medicare Billing
$298,252
Payment Breakdown by Category
Food & Beverage$15,665 (99.0%)
Education$155.67 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,665 | 819 | 99.0% |
| Education | $155.67 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,183 | 106 | $0 (2024) |
| ABBVIE INC. | $1,671 | 102 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,222 | 55 | $0 (2024) |
| PFIZER INC. | $1,140 | 77 | $0 (2024) |
| Novo Nordisk Inc | $798.07 | 55 | $0 (2024) |
| Lilly USA, LLC | $662.33 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $650.63 | 42 | $0 (2024) |
| Amgen Inc. | $545.42 | 15 | $0 (2024) |
| ITI, Inc. | $449.55 | 27 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $444.61 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,078 | 96 | AstraZeneca Pharmaceuticals LP ($452.80) |
| 2023 | $2,272 | 101 | AbbVie Inc. ($503.89) |
| 2022 | $3,025 | 148 | AstraZeneca Pharmaceuticals LP ($493.80) |
| 2021 | $2,102 | 108 | AstraZeneca Pharmaceuticals LP ($435.83) |
| 2020 | $1,709 | 97 | AstraZeneca Pharmaceuticals LP ($398.66) |
| 2019 | $1,407 | 70 | AstraZeneca Pharmaceuticals LP ($526.36) |
| 2018 | $1,605 | 108 | AstraZeneca Pharmaceuticals LP ($288.43) |
| 2017 | $1,624 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($300.67) |
All Payment Transactions
828 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.27 | General |
| 12/13/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: PAIN | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: PAIN | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.22 | General |
| Category: PAIN | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: VACCINES | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: VACCINES | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: PAIN | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 474 | 1,080 | $142,986 | $77,585 |
| 2022 | 5 | 455 | 951 | $123,753 | $68,781 |
| 2021 | 5 | 489 | 967 | $132,952 | $79,505 |
| 2020 | 6 | 552 | 1,147 | $147,136 | $72,381 |
Total Patients
1,970
Total Services
4,145
Medicare Billing
$298,252
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 652 | $75,864 | $39,514 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 359 | $58,452 | $32,914 | 56.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 28 | $6,386 | $3,821 | 59.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $880.00 | $784.45 | 89.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $432.00 | $368.04 | 85.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $972.00 | $183.84 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 381 | $59,436 | $33,816 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 523 | $58,576 | $31,443 | 53.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 22 | $4,620 | $3,024 | 65.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $432.00 | $355.80 | 82.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $689.00 | $141.96 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 224 | 504 | $79,320 | $47,812 | 60.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 211 | 401 | $44,912 | $26,133 | 58.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 34 | $7,140 | $4,455 | 62.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 13 | $1,040 | $848.38 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $540.00 | $257.40 | 47.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 206 | 442 | $68,952 | $35,218 | 51.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 286 | 645 | $72,240 | $33,718 | 46.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 14 | $2,940 | $1,557 | 53.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 12 | 12 | $1,440 | $1,399 | 97.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 20 | 20 | $1,060 | $252.89 | 23.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $504.00 | $235.90 | 46.8% |
About Dr. David Ryan, D.O
Dr. David Ryan, D.O is a Family Medicine healthcare provider based in Kennewick, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912918129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ryan, D.O has received a total of $15,820 in payments from pharmaceutical and medical device companies, with $2,078 received in 2024. These payments were reported across 828 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($15,665).
As a Medicare-enrolled provider, Ryan has provided services to 1,970 Medicare beneficiaries, totaling 4,145 services with total Medicare billing of $298,252. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Kennewick, WA
- Active Since 08/11/2006
- Last Updated 06/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912918129
Products in Payments
- FARXIGA (Drug) $1,732
- JARDIANCE (Drug) $1,147
- ELIQUIS (Drug) $639.81
- VRAYLAR (Drug) $624.10
- BREZTRI (Drug) $516.49
- CAPLYTA (Drug) $514.30
- Kerendia (Drug) $444.61
- UBRELVY (Drug) $418.37
- SYMBICORT (Drug) $380.09
- TRELEGY ELLIPTA (Drug) $345.81
- QULIPTA (Drug) $270.90
- Ozempic (Drug) $237.11
- SPRAVATO (Drug) $231.98
- NEXLETOL (Drug) $230.43
- Repatha (Biological) $223.17
- CREON (Drug) $217.79
- AUBAGIO (Drug) $203.85
- CHANTIX (Drug) $195.67
- Prolia (Biological) $193.75
- LATUDA (Drug) $186.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kennewick
Mark Flesher, M.d, M.D
Family Medicine — Payments: $9,727
Family Medicine $9,727
Dr. Ma Hazel Lyn Gavino, Md, MD
Family Medicine — Payments: $7,543
Family Medicine $7,543
Henrietta Mayuga, Md, MD
Family Medicine — Payments: $4,047
Family Medicine $4,047
Maria Aleli Ello, M.d, M.D
Family Medicine — Payments: $2,751
Family Medicine $2,751
Dr. Mark Macfarlan, Md, MD
Family Medicine — Payments: $2,709
Family Medicine $2,709
Dr. Meneleo Lilagan, M.d, M.D
Family Medicine — Payments: $2,527
Family Medicine $2,527